Theragnostics Ltd   Report issue

For profit Phase 2
Founded: Berkshire United Kingdom (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2018
NCT03617588
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Theragnostics Ltd